Skip to content
Brilliant Blue Biosciences logoBrilliant BlueBiosciences
Articles

Papers, explained in our own words

Every entry summarises what the study set out to test, what it found and why it changes how we design delivery systems. Browse research and reviews or search the collection.

601 articles

Showing 1–1 of 1 articles · Keyword: cell identity Clear keyword

Epigenomics2026ReviewNon-viral Gene DeliveryDrug Delivery

1. Synthetic mRNA engineering beyond prophylactic infectious disease vaccines: epigenomic and molecular reprogramming of diseased cells

Mustafa Am, Kareem Si, Raouf Cg, Ahmed Sm

The clinical validation of mRNA-based COVID-19 vaccines in 2020-2021 accelerated the development of synthetic messenger RNA as a precision therapeutic platform beyond infectious disease prevention. Unlike gene therapy approaches that permanently modify genomic DNA, synthetic mRNA enables transient protein expression…

Read the article
Articles | Brilliant Blue Biosciences